Glyco’s Canadian Patent 2,896,038, has been allowed

“GlycoBioSciences Inc. is pleased to announce, that after having its patents in the US issued/granted in 2017 and 2019, US Patents 9,821,005 and 10,322,142, that cover Glyco’s Ionic Polymer Matrix (IPM) topical delivery technology, and related products, that Glyco has been informed by the Canadian Intellectual Property Office (CIPO) (notice included), that Glyco’s Canadian Patent 2,896,038, has been allowed, and will be issued shortly”.

Read full statement here